Vaccine Adjuvants: Methods and Protocols
Spanning from discoveries in fundamental immunology to industrial and commercial concerns, the study of vaccine adjuvants has developed into an exciting area of work with great, vital potential in innovating techniques in which adjuvants may steer the immune system towards the responses required by...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Totowa, NJ
Humana Press
2010
|
| Schriftenreihe: | Methods in Molecular Biology, Methods and Protocols
626 |
| Schlagworte: | |
| Online-Zugang: | UBR01 TUM01 Volltext |
| Zusammenfassung: | Spanning from discoveries in fundamental immunology to industrial and commercial concerns, the study of vaccine adjuvants has developed into an exciting area of work with great, vital potential in innovating techniques in which adjuvants may steer the immune system towards the responses required by unmet vaccination needs. In Vaccine Adjuvants: Methods and Protocols, expert researchers in the field provide clear and concise guidance on how to go about assessing the activity of adjuvant products. Rather than describing individual adjuvants, the volume strives to include detailed, practical information on measuring the responses produced by adjuvants in order to be relevant to the widest array of experiments. Written in the highly successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and versatile, Vaccine Adjuvants: Methods and Protocols will enable those already pursuing vaccine adjuvant research, while also serving to stimulate discussion on how to best standardize adjuvant testing in order to facilitate meaningful comparisons, and above all, to aid in the prediction of which new products will most effectively and safely help to solve the current challenges in vaccination |
| Beschreibung: | 1 Online-Ressource (X, 314 p) |
| ISBN: | 9781607615859 |
| DOI: | 10.1007/978-1-60761-585-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044950569 | ||
| 003 | DE-604 | ||
| 005 | 20181011 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 180517s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 9781607615859 |9 978-1-60761-585-9 | ||
| 024 | 7 | |a 10.1007/978-1-60761-585-9 |2 doi | |
| 035 | |a (ZDB-2-PRO)978-1-60761-585-9 | ||
| 035 | |a (OCoLC)725243736 | ||
| 035 | |a (DE-599)BVBBV044950569 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-91 | ||
| 050 | 0 | |a QR187.3 | |
| 082 | 0 | |a 571.9645072 |2 22 | |
| 082 | 0 | |a 616.079 |2 23 | |
| 084 | |a VS 9000 |0 (DE-625)147724:253 |2 rvk | ||
| 084 | |a XD 3300 |0 (DE-625)152554:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Vaccine Adjuvants |b Methods and Protocols |c edited by Gwyn Davies |
| 264 | 1 | |a Totowa, NJ |b Humana Press |c 2010 | |
| 300 | |a 1 Online-Ressource (X, 314 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Methods in Molecular Biology, Methods and Protocols |v 626 | |
| 520 | |a Spanning from discoveries in fundamental immunology to industrial and commercial concerns, the study of vaccine adjuvants has developed into an exciting area of work with great, vital potential in innovating techniques in which adjuvants may steer the immune system towards the responses required by unmet vaccination needs. In Vaccine Adjuvants: Methods and Protocols, expert researchers in the field provide clear and concise guidance on how to go about assessing the activity of adjuvant products. Rather than describing individual adjuvants, the volume strives to include detailed, practical information on measuring the responses produced by adjuvants in order to be relevant to the widest array of experiments. Written in the highly successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and versatile, Vaccine Adjuvants: Methods and Protocols will enable those already pursuing vaccine adjuvant research, while also serving to stimulate discussion on how to best standardize adjuvant testing in order to facilitate meaningful comparisons, and above all, to aid in the prediction of which new products will most effectively and safely help to solve the current challenges in vaccination | ||
| 650 | 4 | |a Biomedicine | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Vaccine | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Vaccines | |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Adjuvans |0 (DE-588)4141430-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | 1 | |a Adjuvans |0 (DE-588)4141430-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Davies, Gwyn |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781607615842 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-60761-585-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-PRO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030343330 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-60761-585-9 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-1-60761-585-9 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804178538127949824 |
|---|---|
| any_adam_object | |
| author2 | Davies, Gwyn |
| author2_role | edt |
| author2_variant | g d gd |
| author_facet | Davies, Gwyn |
| building | Verbundindex |
| bvnumber | BV044950569 |
| callnumber-first | Q - Science |
| callnumber-label | QR187 |
| callnumber-raw | QR187.3 |
| callnumber-search | QR187.3 |
| callnumber-sort | QR 3187.3 |
| callnumber-subject | QR - Microbiology |
| classification_rvk | VS 9000 XD 3300 |
| collection | ZDB-2-PRO |
| ctrlnum | (ZDB-2-PRO)978-1-60761-585-9 (OCoLC)725243736 (DE-599)BVBBV044950569 |
| dewey-full | 571.9645072 616.079 |
| dewey-hundreds | 500 - Natural sciences and mathematics 600 - Technology (Applied sciences) |
| dewey-ones | 571 - Physiology & related subjects 616 - Diseases |
| dewey-raw | 571.9645072 616.079 |
| dewey-search | 571.9645072 616.079 |
| dewey-sort | 3571.9645072 |
| dewey-tens | 570 - Biology 610 - Medicine and health |
| discipline | Chemie / Pharmazie Biologie Medizin |
| doi_str_mv | 10.1007/978-1-60761-585-9 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03308nmm a2200553zcb4500</leader><controlfield tag="001">BV044950569</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20181011 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180517s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781607615859</subfield><subfield code="9">978-1-60761-585-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-60761-585-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-60761-585-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)725243736</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044950569</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR187.3</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">571.9645072</subfield><subfield code="2">22</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.079</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9000</subfield><subfield code="0">(DE-625)147724:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3300</subfield><subfield code="0">(DE-625)152554:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vaccine Adjuvants</subfield><subfield code="b">Methods and Protocols</subfield><subfield code="c">edited by Gwyn Davies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 314 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Molecular Biology, Methods and Protocols</subfield><subfield code="v">626</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Spanning from discoveries in fundamental immunology to industrial and commercial concerns, the study of vaccine adjuvants has developed into an exciting area of work with great, vital potential in innovating techniques in which adjuvants may steer the immune system towards the responses required by unmet vaccination needs. In Vaccine Adjuvants: Methods and Protocols, expert researchers in the field provide clear and concise guidance on how to go about assessing the activity of adjuvant products. Rather than describing individual adjuvants, the volume strives to include detailed, practical information on measuring the responses produced by adjuvants in order to be relevant to the widest array of experiments. Written in the highly successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and versatile, Vaccine Adjuvants: Methods and Protocols will enable those already pursuing vaccine adjuvant research, while also serving to stimulate discussion on how to best standardize adjuvant testing in order to facilitate meaningful comparisons, and above all, to aid in the prediction of which new products will most effectively and safely help to solve the current challenges in vaccination</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Adjuvans</subfield><subfield code="0">(DE-588)4141430-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Adjuvans</subfield><subfield code="0">(DE-588)4141430-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Davies, Gwyn</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781607615842</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-60761-585-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030343330</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-60761-585-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-60761-585-9</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV044950569 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:05:33Z |
| institution | BVB |
| isbn | 9781607615859 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030343330 |
| oclc_num | 725243736 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
| owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (X, 314 p) |
| psigel | ZDB-2-PRO |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Humana Press |
| record_format | marc |
| series2 | Methods in Molecular Biology, Methods and Protocols |
| spelling | Vaccine Adjuvants Methods and Protocols edited by Gwyn Davies Totowa, NJ Humana Press 2010 1 Online-Ressource (X, 314 p) txt rdacontent c rdamedia cr rdacarrier Methods in Molecular Biology, Methods and Protocols 626 Spanning from discoveries in fundamental immunology to industrial and commercial concerns, the study of vaccine adjuvants has developed into an exciting area of work with great, vital potential in innovating techniques in which adjuvants may steer the immune system towards the responses required by unmet vaccination needs. In Vaccine Adjuvants: Methods and Protocols, expert researchers in the field provide clear and concise guidance on how to go about assessing the activity of adjuvant products. Rather than describing individual adjuvants, the volume strives to include detailed, practical information on measuring the responses produced by adjuvants in order to be relevant to the widest array of experiments. Written in the highly successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and versatile, Vaccine Adjuvants: Methods and Protocols will enable those already pursuing vaccine adjuvant research, while also serving to stimulate discussion on how to best standardize adjuvant testing in order to facilitate meaningful comparisons, and above all, to aid in the prediction of which new products will most effectively and safely help to solve the current challenges in vaccination Biomedicine Immunology Vaccine Medicine Vaccines Impfstoff (DE-588)4026655-2 gnd rswk-swf Adjuvans (DE-588)4141430-5 gnd rswk-swf Impfstoff (DE-588)4026655-2 s Adjuvans (DE-588)4141430-5 s DE-604 Davies, Gwyn edt Erscheint auch als Druck-Ausgabe 9781607615842 https://doi.org/10.1007/978-1-60761-585-9 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Vaccine Adjuvants Methods and Protocols Biomedicine Immunology Vaccine Medicine Vaccines Impfstoff (DE-588)4026655-2 gnd Adjuvans (DE-588)4141430-5 gnd |
| subject_GND | (DE-588)4026655-2 (DE-588)4141430-5 |
| title | Vaccine Adjuvants Methods and Protocols |
| title_auth | Vaccine Adjuvants Methods and Protocols |
| title_exact_search | Vaccine Adjuvants Methods and Protocols |
| title_full | Vaccine Adjuvants Methods and Protocols edited by Gwyn Davies |
| title_fullStr | Vaccine Adjuvants Methods and Protocols edited by Gwyn Davies |
| title_full_unstemmed | Vaccine Adjuvants Methods and Protocols edited by Gwyn Davies |
| title_short | Vaccine Adjuvants |
| title_sort | vaccine adjuvants methods and protocols |
| title_sub | Methods and Protocols |
| topic | Biomedicine Immunology Vaccine Medicine Vaccines Impfstoff (DE-588)4026655-2 gnd Adjuvans (DE-588)4141430-5 gnd |
| topic_facet | Biomedicine Immunology Vaccine Medicine Vaccines Impfstoff Adjuvans |
| url | https://doi.org/10.1007/978-1-60761-585-9 |
| work_keys_str_mv | AT daviesgwyn vaccineadjuvantsmethodsandprotocols |